Boothbay Fund Management, LLC Myovant Sciences Ltd. Transaction History

Boothbay Fund Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$14.05 - $22.6 $143,843 - $231,378	-10,238 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$7.34 - $20.84 $245,427 - $696,827	-33,437 Reduced 76.56%	10,238 $211,000
Q1 2020 May 15, 2020	BUY	$6.55 - $14.76 $286,071 - $644,643	43,675 New	43,675 $330,000
Q4 2019 Feb 14, 2020	SELL	$4.2 - $19.21 $82,845 - $378,917	-19,725 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$5.19 - $9.46 $102,372 - $186,598	19,725 New	19,725 $103,000

61.3K

Ticker MYOV
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 96,802,800
Description
Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.